260
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Effects of Ultra-Long-Acting Insulin Compared to Long-Acting Insulin on Diabetic Ketoacidosis Incidence in Type 1 Diabetes Mellitus Patients

, , , ORCID Icon, & ORCID Icon
Pages 733-739 | Published online: 05 Mar 2022

Figures & data

Table 1 Sociodemographic and Clinical Characteristics of the Study Participants

Table 2 Measures of Diabetes Clinical Outcomes

Table 3 Total Daily Dose Variation (Sub-Analysis for Both Basal Insulin Types: Glargine U300 and Degludec U100)

Table 4 The Marginal Response of Diabetic Ketoacidosis (DKA)

Table 5 Frequency of Diabetic Ketoacidosis (DKA) Before and After Using Insulin Degludec U100 or Glargine U300; Sub-Analysis